 3D bioprinting technology involves the precise layering of cells, scaffolds, and growth factors to create bio-identical tissue for various uses, with early successes demonstrating advantages over conventional tissue engineering strategies, but current challenges must be addressed before it becomes clinically relevant. This article was authored by Elliot S. Bishop, Sammy Mostafa, Mikhail Pakvesa, and others.